Christophe C.
- Country
- Belgium
- Department
- Oncology for pediatrics
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Data & Insights
Has run more than one trial at 185 of 308 partner sites.
Specializations
Pediatric Hematologic Malignancies
The investigator specializes in treating complex blood cancers affecting children and young adults, with particular focus on acute lymphoblastic leukemia and myeloid leukemia in children with Down Syndrome.
- ALK-positive anaplastic large cell lymphoma
- Treatment optimization for blood disorders
- Sickle cell disease management
Pediatric Brain Tumors
Expertise in treating various types of pediatric brain tumors, particularly focusing on medulloblastoma and ependymoma across different risk classifications.
- High-risk medulloblastoma treatment
- Intracranial ependymoma management
- Advanced radiotherapy approaches
Solid Tumors
Dedicated to advancing treatment protocols for aggressive solid tumors, with special emphasis on neuroblastoma and Ewing sarcoma in pediatric and adolescent patients.
- High-risk neuroblastoma protocols
- Innovative combination therapies
- Targeted therapeutic approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.